Efficacy and safety of Tocilizumab, plasmapheresis and their combination in severe COVID-19: A randomized clinical trial.
Gholinataj Jelodar M, Rafieian S, Saghafi F, Hadad Zedegan N, Birjandi B, Rafieian S, Allah Dini A, Dehghanpour H, Khalaj F, Zare S, Dehghan Chenari H, Hajimaghsoudi M, Mojtaba Sohrevardi S, Mirzaei S, Jamialahmadi T, Atkin SL, Sahebkar A.
Gholinataj Jelodar M, et al. Among authors: rafieian s.
Int Immunopharmacol. 2023 Feb;115:109623. doi: 10.1016/j.intimp.2022.109623. Epub 2022 Dec 21.
Int Immunopharmacol. 2023.
PMID: 36577157
Free PMC article.
Review.